Login to Your Account

Change needed to harness the knowledge of real-world evidence

By Mari Serebrov
Regulatory Editor

Thursday, September 14, 2017

The FDA may be under a congressional mandate to advance the use of real-world evidence in its regulatory decisions, but many of the obstacles in getting the patient data needed to generate that evidence are beyond the agency's reach.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription